A subset of Binet stage A CLL patients with TP53 abnormalities and mutated IGHV genes have stable disease.
作者： O G Best , A C Gardiner , Z A Davis , I Tracy , R E Ibbotson
DOI: 10.1038/LEU.2008.260
关键词:
摘要: A subset of Binet stage CLL patients with TP53 abnormalities and mutated IGHV genes have stable disease
nature.com
sci-hub.se 参考文章(8)
David G. Oscier, Anne C. Gardiner, Sarah J. Mould, Sharron Glide, Zadie A. Davis, Rachel E. Ibbotson, Martin M. Corcoran, Robert M. Chapman, Peter W. Thomas, J. Adrian Copplestone, Jenny A. Orchard, Terry J. Hamblin, Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood. ,vol. 100, pp. 1177- 1184 ,(2002) , 10.1182/BLOOD.V100.4.1177.H81602001177_1177_1184
C. Ian Mockridge, Kathleen N. Potter, Isla Wheatley, Louise A. Neville, Graham Packham, Freda K. Stevenson, Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status. Blood. ,vol. 109, pp. 4424- 4431 ,(2007) , 10.1182/BLOOD-2006-11-056648
A R Pettitt, E Matutes, D Oscier, Alemtuzumab in combination with high-dose methylprednisolone is a logical, feasible and highly active therapeutic regimen in chronic lymphocytic leukaemia patients with p53 defects. Leukemia. ,vol. 20, pp. 1441- 1445 ,(2006) , 10.1038/SJ.LEU.2404265
O G Best, A C Gardiner, A Majid, R Walewska, B Austen, A Skowronska, R Ibbotson, T Stankovic, M J S Dyer, D G Oscier, A novel functional assay using etoposide plus nutlin-3a detects and distinguishes between ATM and TP53 mutations in CLL. Leukemia. ,vol. 22, pp. 1456- 1459 ,(2008) , 10.1038/SJ.LEU.2405092
Rebecca L. Auer, John Gribben, Finbarr E. Cotter, Emerging therapy for chronic lymphocytic leukaemia British Journal of Haematology. ,vol. 139, pp. 635- 644 ,(2007) , 10.1111/J.1365-2141.2007.06877.X
D Catovsky, S Richards, E Matutes, D Oscier, MJS Dyer, RF Bezares, AR Pettitt, T Hamblin, DW Milligan, JA Child, MS Hamilton, CE Dearden, AG Smith, AG Bosanquet, Z Davis, V Brito-Babapulle, M Else, R Wade, P Hillmen, Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial The Lancet. ,vol. 370, pp. 230- 239 ,(2007) , 10.1016/S0140-6736(07)61125-8
Hartmut Döhner, Stephan Stilgenbauer, Axel Benner, Elke Leupolt, Alexander Kröber, Lars Bullinger, Konstanze Döhner, Martin Bentz, Peter Lichter, Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia The New England Journal of Medicine. ,vol. 343, pp. 1910- 1916 ,(2000) , 10.1056/NEJM200012283432602
Thorsten Zenz, Martin Trbusek, Jana Smardova, Sonja Häbe, Tina Denzel, Jitka Malcikova, Michael Doubek, Jiri Schwarz, Hartmut Dohner, Stephan Stilgenbauer, p53 Inactivation in CLL: Pattern of 110 TP53 Mutations Blood. ,vol. 110, pp. 2064- 2064 ,(2007) , 10.1182/BLOOD.V110.11.2064.2064